MAPT and Alzheimer disease: Interestingly, a VDAC-1 heterozygous mouse model (VDAC-1+/−) showed reduced mRNA levels for AD-related genes such as Aβ, APP, and tau, demonstrating that a reduced VDAC-1 expression level protects from AD-mediated neurotoxicity [142].